Paper
0
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Authors
Published
Dec 12, 2017
Show more
Save
Tip0
TipSave
Abstract
Low-molecular-weight heparin is the standard treatment for cancer-associated venous thromboembolism. The role of treatment with direct oral anticoagulant agents is unclear.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.